Advertisement

Ventilatory Support and Oxygen Therapy in the Elderly Palliative and End-of-Life Care Patients

  • Antonello Nicolini
  • Teresa Diaz de Teran
  • Catia Cillòniz
Chapter

Abstract

An ageing population and steady increase in the rates of neoplasms and chronic degenerative diseases poses a challenge for societies and their healthcare systems. Because of the recent and continued advances in therapies, such as the development and widespread use of non-invasive ventilation (NIV), survival rates have increased for these pathologies. For patients with end-stage chronic respiratory diseases, the use of NIV following the onset of acute or severe chronic respiratory failure is a valid option when intubation has been excluded. The available evidence strongly supports the use of NIV in patients presenting with an exacerbation of COPD, as well end-stage neuromuscular disease. Few studies support the use of NIV in end-stage interstitial lung disease. In patients with cancer it has been recommended offering NIV as palliative care to improve dyspnoea. The decision regarding the treatment should be made by the patient, ideally before reaching the terminal stage and after having a frank dialogue with healthcare professionals and family members.

References

  1. 1.
    Nunez Olarte JM, Guillen DG. Cultural issues and ethical dilemmas in palliative and end of life care in Spain. Cancer Control. 2001;8:46–54.CrossRefGoogle Scholar
  2. 2.
    American Thoracic Society. International consensus conferences in intensive care medicine: noninvasive positive pressure ventilation in acute respiratory failure. Am J Respir Crit Care Med. 2001;163:283–91.CrossRefGoogle Scholar
  3. 3.
    Rochwerg B, Brochard L, Elliott MW, et al. Official ERS/ATS clinical practice guidelines: non-invasive ventilation for acute respiratory failure. Eur Respir J. 2017;50:1602426.  https://doi.org/10.1183/13993003.02426-2016.CrossRefPubMedGoogle Scholar
  4. 4.
    Nava S, Sturani C, Hartl S, et al. End-of-life decision-making in respiratory intermediate care units: a European survey. Eur Respir J. 2007;30:156–64.CrossRefGoogle Scholar
  5. 5.
    Dales RE, O’Connor A, Hebert P, Sullivan K, McKim D, Llewellyn-Thomas H. Intubation and mechanical ventilation for COPD: development of an instrument to elicit patient preferences. Chest. 1999;116:792–800.CrossRefGoogle Scholar
  6. 6.
    Murray I, Paterson E, Thain G, Currie GP. Outcomes following non-invasive ventilation for hypercapnic exacerbations of chronic obstructive pulmonary disease. Thorax. 2011;66:825–6.CrossRefGoogle Scholar
  7. 7.
    Chu CM, Chan VL, Lin AW, Wong IW, Leung WS, Lai CK. Readmission rates and life threatening events in COPD survivors treated with non-invasive ventilation for acute hypercapnic respiratory failure. Thorax. 2004;59:1020–5.CrossRefGoogle Scholar
  8. 8.
    Murphy PB, Rehal S, Arbane G, Bourke S, Calverley PMA, Crook AM, Dowson L, Duffy N, Gibson GJ, Hughes PD, Hurst JR, Lewis KE, Mukherjee R, Nickol A, Oscroft N, Patout M, Pepperell J, Smith I, Stradling JR, Wedzicha JA, Polkey MI, Elliott MW, Hart N. Effect of home noninvasive ventilation with oxygen therapy vs oxygen therapy alone on hospital readmission or death after an acute COPD exacerbation a randomized clinical trial. JAMA. 2017;317:2177–86.CrossRefGoogle Scholar
  9. 9.
    Nicolini A, Santo M, Ferrera L, Ferrari-Bravo M, Barlascini C, Perazzo A. The use of non-invasive ventilation in very old patients with hypercapnic acute respiratory failure because of COPD exacerbation. Int J Clin Pract. 2014;68:1523–9.CrossRefGoogle Scholar
  10. 10.
    Annane D, Quera-Salva MA, Lofaso F, Verken JB, Lesieur O, Fromageot C. Mechanisms underlying the effects of nocturnal ventilation on daytime blood gases in neuromuscular diseases. Eur Respir J. 1999;13:157–62.CrossRefGoogle Scholar
  11. 11.
    Nickol AN, Hart N, Hopkinson NS, Moxham J, Simonds A, Polkey MI. Mechanisms of improvement of respiratory failure in patients with restrictive thoracic disease treated with non-invasive ventilation. Thorax. 2005;60:754–60.CrossRefGoogle Scholar
  12. 12.
    Oliver DJ, Turner MR. Some difficult decisions in ALS/MND. Amyotroph Lateral Scler. 2010;11:339–43.CrossRefGoogle Scholar
  13. 13.
    Vianello A, Arcaro G, Battistella L, Pipitone E, Vio S, Concas A, et al. Noninvasive ventilation in the event of acute respiratory failure in patients with idiopathic pulmonary fibrosis. J Crit Care. 2014;29:562–7.CrossRefGoogle Scholar
  14. 14.
    Papiris SA, Manali ED, Kolilekas L, Kagouridis K, Triantafillidou C, Tsangaris I, et al. Clinical review: idiopathic pulmonary fibrosis acute exacerbations-unravelling Ariadne’s thread. Crit Care. 2010;14:246.CrossRefGoogle Scholar
  15. 15.
    Curtis JR, Cook DJ, Sinuff T, et al. Noninvasive positive pressure ventilation in critical and palliative care settings: understanding the goals of therapy. Crit Care Med. 2007;35:932–9.CrossRefGoogle Scholar
  16. 16.
    Rabbat A, Chaoui D, Montani D, et al. Prognosis of patients with acute myeloid leukaemia admitted to intensive care. Br J Haematol. 2005;129:350–7.CrossRefGoogle Scholar
  17. 17.
    Ferreira JC, et al. Risk factors for non-invasive ventilation failure in cancer patients in the intensive care unit: a retrospective cohort study. J Crit Care. 2015;30:1003–7.CrossRefGoogle Scholar
  18. 18.
    Hui D, Morgado M, Chisholm G, et al. High-flow oxygen and bilevel positive airway pressure for persistent dyspnea in patients with advanced cancer: a phase II randomized trial. J Pain Symptom Manag. 2013;46:463–73.CrossRefGoogle Scholar
  19. 19.
    Nava S, Ferrer M, Esquinas A, et al. Palliative use of non-invasive ventilation in end-of-life patients with solid tumours: a randomised feasibility trial. Lancet Oncol. 2013;14:219–27.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Antonello Nicolini
    • 1
  • Teresa Diaz de Teran
    • 2
  • Catia Cillòniz
    • 3
  1. 1.Respiratory Diseases UnitGeneral HospitalSestri LevanteItaly
  2. 2.Sleep and Non Invasive Ventilation Unit, PulmonaryHospital Universitario Marqués de ValdecillaSantanderSpain
  3. 3.Department of Pneumology, Institut Clinic del TóraxHospital Clinic of Barcelona—Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona (UB)—SGR 911-Ciber de Enfermedades Respiratorias (Ciberes)BarcelonaSpain

Personalised recommendations